We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

210 hedge funds and large institutions have $239M invested in ImmunityBio in 2025 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 76 increasing their positions, 41 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 41

38% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 32

13% more capital invested

Capital invested by funds: $212M → $239M (+$27.6M)

4% more funds holding

Funds holding: 201 → 210 (+9)

2% less ownership

Funds ownership: 11.32% → 9.33% (-2%)

43% less call options, than puts

Call options by funds: $7.5M | Put options by funds: $13.2M

Holders
210
Holders Change
+9
Holders Change %
+4.48%
% of All Funds
2.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
76
Reduced
41
Closed
32
Calls
$7.5M
Puts
$13.2M
Net Calls
-$5.68M
Net Calls Change
-$4.04M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$9.14M
2
Citigroup
Citigroup
New York
+$7.06M
3
Group One Trading
Group One Trading
Illinois
+$2.57M
4
Verition Fund Management
Verition Fund Management
Connecticut
+$2.35M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.36M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$7.68M
2
State Street
State Street
Massachusetts
-$6.67M
3
Morgan Stanley
Morgan Stanley
New York
-$6.4M
4
PA
Perceptive Advisors
New York
-$3.13M
5
ACM
Altium Capital Management
New York
-$2.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
WC
226
Wexford Capital
Florida
– -$84.8K -33,113 Closed
DFCM
227
Dark Forest Capital Management
Puerto Rico
– -$64.4K -25,144 Closed
CIBC Asset Management
228
CIBC Asset Management
Ontario, Canada
– -$52.6K -20,539 Closed
CF
229
Copperwynd Financial
Arizona
– -$51.4K -20,087 Closed
FAN
230
Financial Advisors Network
California
– -$51.2K -20,000 Closed
CA
231
Continuum Advisory
Idaho
– -$38.5K -15,030 Closed
SIA
232
Schechter Investment Advisors
Michigan
– -$38.4K -15,000 Closed
BFG
233
Bleakley Financial Group
New Jersey
– -$36.1K -14,095 Closed
SI
234
Stephens Inc
Arkansas
– -$25.8K -10,090 Closed
QT
235
Quantbot Technologies
New York
– -$12.1K -4,722 Closed
VHAM
236
Van Hulzen Asset Management
California
– -$512 -200 Closed
IA
237
IFP Advisors
Florida
– -$218 -85 Closed
HWM
238
Hemington Wealth Management
Virginia
– -$230 -76 -48%
CA
239
CoreCap Advisors
Michigan
– -$179 -70 Closed
C
240
Covestor
United Kingdom
– +$88 +29 +83%
6 7 8 9
10

IBRX Hedge Fund Activity: Q1 2025 in Review

210 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q1 2025, worth a combined $239M — up 13% from $212M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new IBRX positions and 32 closed out — a net gain of 12 holders — while 76 added to existing stakes and 41 trimmed.

The largest buyer was Vanguard Group, adding an estimated $9.14M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $7.68M sold.

  • 210 institutional investors held ImmunityBio (IBRX) as of Q1 2025, up from 201 in Q4 2024.
  • Funds reported $239M of ImmunityBio stock for Q1 2025, up 13% quarter-over-quarter.
  • 44 funds opened new ImmunityBio positions in Q1 2025 and 32 closed out, a net change of +12 holders.
  • The largest ImmunityBio buyer in Q1 2025 was Vanguard Group, an estimated $9.14M added.
  • The largest ImmunityBio seller in Q1 2025 was Cormorant Asset Management, an estimated $7.68M sold.

Based on aggregated 13F filings for Q1 2025.